Adrian Kinkaid Purchases 83,728 Shares of Fusion Antibodies plc (LON:FAB) Stock

Fusion Antibodies plc (LON:FAB) insider Adrian Kinkaid bought 83,728 shares of the business’s stock in a transaction dated Wednesday, October 16th. The shares were purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £3,349.12 ($4,373.36).

Adrian Kinkaid also recently made the following trade(s):

• On Wednesday, September 4th, Adrian Kinkaid purchased 120,000 shares of Fusion Antibodies stock. The shares were purchased at an average price of GBX 3 ($0.04) per share, for a total transaction of £3,600 ($4,700.97).

Fusion Antibodies Price Performance

Shares of LON FAB opened at GBX 4.20 ($0.05) on Friday. The stock has a market cap of £4.01 million, a P/E ratio of -105.00 and a beta of 0.49. Fusion Antibodies plc has a twelve month low of GBX 2.80 ($0.04) and a twelve month high of GBX 9.50 ($0.12). The stock has a 50 day moving average of GBX 3.69 and a two-hundred day moving average of GBX 3.53. The company has a current ratio of 3.87, a quick ratio of 2.36 and a debt-to-equity ratio of 2.40.

About Fusion Antibodies

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services.